论文部分内容阅读
我院于1985年至1986年使用由北京东风制药厂生产的小牛胸腺肽制剂综合治疗婴幼儿重症肺炎,对其临床疗效进行了观察,现将结果报告如下: 临床资料病例选择1.对象:两组病例系采用随机抽样方式,事先订立治疗方案及观察项目。设有观察组及对照组各24例。观察组中男15例,女9例,对照组中男10例,女14例。年龄在1岁以下者观察组为12例,对照组为11例,1～2岁观察组为9例,对照组为10例,2岁以上两组均为3例。2.诊断依据:①高热3天以上,
Our hospital from 1985 to 1986 by the Beijing Dongfeng Pharmaceutical Factory calf thymus preparation comprehensive treatment of severe pneumonia in infants and young children, its clinical efficacy was observed, the results are reported as follows: Clinical data Case Selection 1. Subjects: two The patients were randomly selected by random sampling, and the treatment programs and observation items were concluded in advance. There are 24 cases in observation group and control group. The observation group, 15 males and 9 females, the control group of 10 males and 14 females. There were 12 cases in the observation group under the age of 1, 11 cases in the control group, 9 cases in the 1 ~ 2 years old observation group, 10 cases in the control group and 3 cases in the 2 years and above group. 2. Diagnosis is based on: ① high fever more than 3 days,